• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pathogenesis of Uveitic Glaucoma.葡萄膜炎性青光眼的发病机制
J Curr Glaucoma Pract. 2018 Sep-Dec;12(3):125-138. doi: 10.5005/jp-journals-10028-1257.
2
PATHOGENESIS AND CURRENT METHODS OF TREATMENT OF SECONDARY UVEITIC GLAUCOMA. A REVIEW.继发性葡萄膜炎性青光眼的发病机制与治疗方法研究进展。综述。
Cesk Slov Oftalmol. 2023 Spring;79(3):111-115. doi: 10.31348/2023/7.
3
Overcoming diagnostic and treatment challenges in uveitic glaucoma.克服葡萄膜炎性青光眼的诊断和治疗挑战。
Clin Exp Optom. 2019 Mar;102(2):109-115. doi: 10.1111/cxo.12811. Epub 2018 Jul 29.
4
[Physiopathology of uveitic glaucoma].[葡萄膜炎性青光眼的病理生理学]
Klin Monbl Augenheilkd. 1997 May;210(5):269-73. doi: 10.1055/s-2008-1035052.
5
The Pathogenesis of Raised Intraocular Pressure in Uveitis.葡萄膜炎中眼压升高的发病机制
Curr Eye Res. 2016;41(2):137-49. doi: 10.3109/02713683.2015.1017650. Epub 2015 May 14.
6
High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis.葡萄膜炎患者中由眼压升高到青光眼的转化率很高。
Br J Ophthalmol. 2022 Nov;106(11):1520-1523. doi: 10.1136/bjophthalmol-2021-318809. Epub 2021 May 21.
7
The Management of Uveitic Glaucoma in Children.儿童葡萄膜炎性青光眼的管理
Turk J Ophthalmol. 2019 Oct 24;49(5):283-293. doi: 10.4274/tjo.galenos.2019.36589.
8
Current management of uveitis-associated ocular hypertension and glaucoma.葡萄膜炎相关性眼压升高和青光眼的当前治疗方法。
Surv Ophthalmol. 2020 Jul-Aug;65(4):397-407. doi: 10.1016/j.survophthal.2019.12.003. Epub 2019 Dec 6.
9
Uveitis and glaucoma: new insights in the pathogenesis and treatment.葡萄膜炎与青光眼:发病机制与治疗的新见解
Prog Brain Res. 2015;221:243-69. doi: 10.1016/bs.pbr.2015.06.008. Epub 2015 Oct 1.
10
Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented?使用Baerveldt植入物治疗严重葡萄膜炎性青光眼的疗效:能否预防失明?
Acta Ophthalmol. 2018 Feb;96(1):24-30. doi: 10.1111/aos.13489. Epub 2017 Sep 18.

引用本文的文献

1
Advances in the management of uveitic cataract: current strategies and emerging perspectives.葡萄膜炎性白内障的治疗进展:当前策略与新观点
Int Ophthalmol. 2025 Aug 21;45(1):343. doi: 10.1007/s10792-025-03695-z.
2
Prevalence of glaucoma in Africa: A systematic review and Bayesian meta-analysis.非洲青光眼的患病率:系统评价与贝叶斯荟萃分析
PLoS One. 2025 Aug 14;20(8):e0330567. doi: 10.1371/journal.pone.0330567. eCollection 2025.
3
A Case of Intraocular Pressure Elevation Secondary to Pupillary Occlusion.瞳孔阻滞继发眼压升高1例
Cureus. 2025 May 27;17(5):e84917. doi: 10.7759/cureus.84917. eCollection 2025 May.
4
Ab externo open conjunctiva XEN 63 μm: a novel surgical alternative in uveitic glaucoma-a case report.经结膜外开放植入63μm XEN:葡萄膜炎性青光眼的一种新型手术选择——病例报告
J Ophthalmic Inflamm Infect. 2025 Apr 10;15(1):37. doi: 10.1186/s12348-025-00493-7.
5
The PAUL Glaucoma Implant in the management of uveitic glaucoma-3-year follow-up.保罗青光眼植入物治疗葡萄膜炎性青光眼的3年随访
Eye (Lond). 2025 Apr;39(5):931-937. doi: 10.1038/s41433-024-03527-x. Epub 2024 Dec 2.
6
Treatment of uveitis and scleritis patients in Malaysia.马来西亚葡萄膜炎和巩膜炎患者的治疗。
Int J Ophthalmol. 2024 Mar 18;17(3):518-527. doi: 10.18240/ijo.2024.03.14. eCollection 2024.
7
Update on Diagnosis and Treatment of Uveitic Glaucoma.葡萄膜炎性青光眼的诊断与治疗进展
J Clin Med. 2024 Feb 20;13(5):1185. doi: 10.3390/jcm13051185.
8
The association between intraocular pressure dynamics during dark-room prone testing and intraocular pressure over a relatively long-term follow-up period in primary open-glaucoma patients.原发性开角型青光眼患者暗室俯卧试验期间眼压动态变化与相对长期随访期间眼压的关系。
Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):949-956. doi: 10.1007/s00417-023-06257-0. Epub 2023 Oct 21.
9
Efficacy of ripasudil in reducing intraocular pressure and medication score for ocular hypertension with inflammation and corticosteroid.ripasudil降低炎症和皮质类固醇性高眼压症眼压及用药评分的疗效
Int J Ophthalmol. 2023 Jun 18;16(6):904-908. doi: 10.18240/ijo.2023.06.11. eCollection 2023.
10
Features of hemodynamic and immunological parameters in patients with recurrent uveitis complicated by hypertension, Fuchs heterochromic uveitis and Posner-Schlossman syndrome.反复发作性葡萄膜炎合并高血压、Fuchs 异色性虹膜睫状体炎和 Posner-Schlossman 综合征患者的血流动力学和免疫参数特征。
Rom J Ophthalmol. 2023 Jan-Mar;67(1):20-32. doi: 10.22336/rjo.2023.5.

本文引用的文献

1
First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery.在接受青光眼滤过手术的开角型青光眼患者中进行的ISTH0036(一种选择性靶向转化生长因子β2(TGF-β2)的反义寡核苷酸)首次人体I期研究。
PLoS One. 2017 Nov 30;12(11):e0188899. doi: 10.1371/journal.pone.0188899. eCollection 2017.
2
Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis.阿达木单抗每周治疗对幼年特发性关节炎和儿童慢性葡萄膜炎的安全性。
Clin Rheumatol. 2018 Feb;37(2):549-553. doi: 10.1007/s10067-017-3890-4. Epub 2017 Nov 4.
3
Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.阿达木单抗用于治疗青少年特发性关节炎性葡萄膜炎。
N Engl J Med. 2017 Aug 24;377(8):789. doi: 10.1056/NEJMc1708646.
4
Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.阿达木单抗用于治疗青少年特发性关节炎性葡萄膜炎
N Engl J Med. 2017 Aug 24;377(8):789-790. doi: 10.1056/NEJMc1708646.
5
Profile of adalimumab and its potential in the treatment of uveitis.阿达木单抗简介及其在葡萄膜炎治疗中的潜力。
Drug Des Devel Ther. 2016 Sep 19;10:2997-3003. doi: 10.2147/DDDT.S94188. eCollection 2016.
6
Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography.眼部结节病的临床表现、并发症及治疗:光学相干断层扫描显示的视觉效率与黄斑水肿之间的相关性
Semin Ophthalmol. 2016 Sep 14:1-8. doi: 10.1080/08820538.2016.1206576.
7
Uveitic macular edema.葡萄膜炎性黄斑水肿
Eye (Lond). 2016 Oct;30(10):1277-1292. doi: 10.1038/eye.2016.115. Epub 2016 Jun 3.
8
Factors Influencing Aqueous Proinflammatory Cytokines and Growth Factors in Uveitic Glaucoma.葡萄膜炎性青光眼房水促炎细胞因子和生长因子的影响因素
PLoS One. 2016 Jan 15;11(1):e0147080. doi: 10.1371/journal.pone.0147080. eCollection 2016.
9
Ocular hypertension and hypotony as determinates of outcomes in uveitis.高眼压和低眼压作为葡萄膜炎预后的决定因素。
Clin Ophthalmol. 2015 Dec 7;9:2291-8. doi: 10.2147/OPTH.S90636. eCollection 2015.
10
Current Approach in the Diagnosis and Management of Uveitic Glaucoma.葡萄膜炎性青光眼的诊断与治疗现状
Biomed Res Int. 2015;2015:742792. doi: 10.1155/2015/742792. Epub 2015 Oct 19.

葡萄膜炎性青光眼的发病机制

Pathogenesis of Uveitic Glaucoma.

作者信息

Kalogeropoulos Dimitrios, Sung Velota Ct

机构信息

Birmingham and Midland Eye Centre, Sandwell and West Birmingham Hospital, NHS Trust, UK.

出版信息

J Curr Glaucoma Pract. 2018 Sep-Dec;12(3):125-138. doi: 10.5005/jp-journals-10028-1257.

DOI:10.5005/jp-journals-10028-1257
PMID:31354205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6647826/
Abstract

UNLABELLED

Uveitic glaucoma consists one of the most serious complications of intraocular inflammation and, despite its rarity, is considered as one of the leading causes of preventable loss of vision worldwide. It has been associated with a wide spectrum of inflammatory diseases, but its pathogenesis is still not fully comprehended. It appears that the type of inflammation, the steroid-response and the anatomical alterations of the anterior chamber play a pivotal role. To our knowledge, the mechanisms may be both acute and chronic. The main targets of the treatment are to control the inflammation and reduce the intraocular pressure (IOP). The management of glaucoma associated with uveitis remains an extremely challenging condition for ophthalmologists. The successful treatment of uveitic glaucoma is inextricably correlated with prompt and immediate therapeutic decisions. Very often a solid collaboration between clinicians from different specialties may be required for treating the underlying disease. Further understanding of its pathogenesis can indicate therapeutic targets and may lead to the development of new and more efficient therapeutic approaches. New glaucoma surgical modalities may ameliorate the prognosis after surgical intervention, but this calls for further evaluation. This study aims to highlight the complexity of uveitic glaucoma analyzing the main pathogenetic mechanisms and the correlations with the inflammatory response.

HOW TO CITE THIS ARTICLE

Kalogeropoulos D, Sung VCT. Pathogenesis of Uveitic Glaucoma. J Curr Glaucoma Pract 2018;12(3):125-138.

摘要

未标注

葡萄膜炎性青光眼是眼内炎症最严重的并发症之一,尽管其罕见,但被认为是全球可预防视力丧失的主要原因之一。它与多种炎症性疾病相关,但其发病机制仍未完全明了。似乎炎症类型、类固醇反应和前房的解剖改变起关键作用。据我们所知,其机制可能既有急性的也有慢性的。治疗的主要目标是控制炎症和降低眼压(IOP)。葡萄膜炎相关性青光眼的治疗对眼科医生来说仍然是极具挑战性的情况。葡萄膜炎性青光眼的成功治疗与迅速即时的治疗决策密切相关。治疗潜在疾病时,不同专科的临床医生之间常常需要紧密合作。对其发病机制的进一步了解可以指明治疗靶点,并可能导致新的、更有效的治疗方法的发展。新的青光眼手术方式可能改善手术干预后的预后,但这需要进一步评估。本研究旨在通过分析主要发病机制以及与炎症反应的相关性,突出葡萄膜炎性青光眼的复杂性。

如何引用本文

卡洛耶罗普洛斯D,宋VCT。葡萄膜炎性青光眼的发病机制。《当代青光眼实践杂志》2018;12(3):125 - 138。